Targeting cardiac fibrosis with engineered T cells - Capstan Therapeutics

Capstan Therapeutics

Home
Company
Pipeline
Science & Platform
News & Publications
Culture & Careers
Contact

09/11/2019

Share

Company
Science & Platform
Pipeline
Culture & Careers
News & Publications
Contact

Capstan Therapeutics is now part of AbbVie.

To learn more about the announcement, click the button below.

READ THE ANNOUNCEMENT